Pasar al contenido principal

TRANSICION MESOTELIO-MESENQUIMAL COMO DIANA TERAPEUTICA EN FIBROSIS PERITONEAL Y EN METASTASIS

PID2022-142796OB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2022
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Calprotectin blockade inhibits long-term vascular pathology following peritoneal dialysis-associated bacterial infection

  • Cetin, Esra
  • Mazzarino, Morgane
  • González-Mateo, Guadalupe T.
  • Kopytina, Valeria
  • Meran, Soma
  • Fraser, Donald
  • López-Cabrera, Manuel
  • Labéta, Mario O
  • Raby, Anne Catherine
Bacterial infections and the concurrent inflammation have been associated with increased long-term cardiovascular (CV) risk. In patients receiving peritoneal dialysis (PD), bacterial peritonitis is a common occurrence, and each episode further increases late CV mortality risk. However, the underlying mechanism(s) remains to be elucidated before safe and efficient anti-inflammatory interventions can be developed. Damage-Associated Molecular Patterns (DAMPs) have been shown to contribute to the acute inflammatory response to infections, but a potential role for DAMPs in mediating long-term vascular inflammation and CV risk following infection resolution in PD, has not been investigated. We found that bacterial peritonitis in mice that resolved within 24h led to CV disease-promoting systemic and vascular immune-mediated inflammatory responses that were maintained up to 28 days. These included higher blood proportions of inflammatory leukocytes displaying increased adhesion molecule expression, higher plasma cytokines levels, and increased aortic inflammatory and atherosclerosis-associated gene expression. These effects were also observed in infected nephropathic mice and amplified in mice routinely exposed to PD fluids. A peritonitis episode resulted in elevated plasma levels of the DAMP Calprotectin, both in PD patients and mice, here the increase was maintained up to 28 days. In vitro, the ability of culture supernatants from infected cells to promote key inflammatory and atherosclerosis-associated cellular responses, such as monocyte chemotaxis, and foam cell formation, was Calprotectin-dependent. In vivo, Calprotectin blockade robustly inhibited the short and long-term peripheral and vascular consequences of peritonitis, thereby demonstrating that targeting of the DAMP Calprotectin is a promising therapeutic strategy to reduce the long-lasting vascular inflammatory aftermath of an infection, notably PD-associated peritonitis, ultimately lowering CV risk., This work was supported by a fellowship from Kidney Research UK (PDF1/2015), an endowment fund from the Wales Heart Research Institute and a project grant from the British Heart Foundation (PG/22/11062, to A-CR), as well as funds from the European Union Horizon 2020-funded project IMPROVE-PD (Marie Sklodowska-Curie) and Health and Care Research Wales (to the Wales Kidney Research Unit, Head DF). ML-C was funded by the Spanish Ministry of Science and Innovation/Fondo Europeo de Desarrollo Regional (MICIN/FEDER, PID2022-142796OB-I00/AEI/10.13039/501100011033)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

HDAC1/2 control mesothelium/ovarian cancer adhesive interactions impacting on Talin-1-α5β1-integrin-mediated actin cytoskeleton and extracellular matrix protein remodeling

  • Terri, Michela
  • Sandoval, Pilar
  • Bontempi, Giulio
  • Montaldo, Claudia
  • Tomero-Sanz, Henar
  • Turris, Valeria de
  • Trionfetti, Flavia
  • Pascual-Antón, Lucía
  • Clares, Irene
  • Battistelli, Cecilia
  • Valente, Sergio
  • Zwergel, Clemens
  • Mai, Antonello
  • Rosanò, Laura
  • Pozo, Miguel Angel
  • Sánchez-Álvarez, Miguel
  • Cabañas, Carlos
  • Tripodi, Marco
  • López-Cabrera, Manuel
  • Strippoli, Raffaele
[Background]: Peritoneal metastasis, which accounts for 85% of all epithelial ovarian carcinoma (EOC) metastases, is a multistep process that requires the establishment of adhesive interactions between cancer cells and the peritoneal membrane. Interrelations between EOC and the mesothelial stroma are critical to facilitate the metastatic process. No data is available so far on the impact of histone acetylation/deacetylation, a potentially relevant mechanism governing EOC metastasis, on mesothelial cells (MCs)-mediated adhesion., [Methods]: Static adhesion and peritoneal clearance experiments were performed pretreating mesenchymal-like MCs and platinum—sensitive/resistant EOC cell lines with MS-275—a Histone deacetylase (HDAC)1–3 pharmacological inhibitor currently used in combination trials. Results were acquired by confocal microscopy and were analyzed with an automated Opera software. The role of HDAC1/2 was validated by genetic silencing. The role of α4-, α5-α1 Integrins and Fibronectin-1 was validated using specific monoclonal antibodies. Quantitative proteomic analysis was performed on primary MCs pretreated with MS-275. Decellularized matrices were generated from either MS-275-exposed or untreated cells to study Fibronectin-1 extracellular secretion. The effect of MS-275 on β1 integrin activity was assessed using specific monoclonal antibodies. The role of Talin-1 in MCs/EOC adhesion was analyzed by genetic silencing. Talin-1 ectopic expression was validated as a rescue tool from MS-275-induced phenotype. The in vivo effect of MS-275-induced MC remodeling was validated in a mouse model of peritoneal EOC dissemination., [Results]: Treatment of MCs with non-cytotoxic concentrations of MS-275 caused a consistent reduction of EOC adhesion. Proteomic analysis revealed several pathways altered upon MC treatment with MS-275, including ECM deposition/remodeling, adhesion receptors and actin cytoskeleton regulators. HDAC1/2 inhibition hampered actin cytoskeleton polymerization by downregulating actin regulators including Talin-1, impairing β1 integrin activation, and leading to abnormal extracellular secretion and distribution of Fibronectin-1. Talin-1 ectopic expression rescued EOC adhesion to MS-275-treated MCs. In an experimental mouse model of metastatic EOC, MS-275 limited tumor invasion, Fibronectin-1 secretion and the sub-mesothelial accumulation of MC-derived carcinoma-associated fibroblasts., [Conclusion]: Our study unveils a direct impact of HDAC-1/2 in the regulation of MC/EOC adhesion and highlights the regulation of MC plasticity by epigenetic inhibition as a potential target for therapeutic intervention in EOC peritoneal metastasis., This research was funded by: AIRC (Associazione Italiana per la Ricerca sul Cancro) (IG26172) and Ateneo Sapienza Project 2020 (RG120172B8E53D03) to S.V; by FISR2019_00374 MeDyCa to AM; by FSE REACT-EU within the program PON “Research and Innovation” 2014–2020, Action IV.6 “Contratti di ricerca su tematiche Green” to CZ; by SEED PNR 2021 to C.B.; by AIRC IG26290, by Sapienza University of Rome (RG11916B6A9C42C7) to M. Tr and by Ministry for Health of Italy (Ricerca Corrente), by AIRC (IG21372 to LR), by PRIN 2022 PNRR (P2022XZKBM) financed by the European Union - NextGenerationEU», to RS. This work was also supported by grants (PID2019-110132RB-I00/AEI/https://doi.org/10.13039/501100011033 and PID2022-142796OB-I00/AEI/https://doi.org/10.13039/501100011033)) from the Spanish Ministry of Science and Innovation/Fondo Europeo de Desarrollo Regional (MICIN/FEDER) to ML-C and by a grant PID2021-123199OB-I00 from the Spanish Ministry of Science and Innovation/Fondo Europeo de Desarrollo Regional (MICIN/FEDER) to CC. MAdP is recipient/co-recipient of funding from the Spanish Ministry of Science and Innovation (MCIN) (refs. SAF2017–83130-R cofunded by “ERDF A way of making Europe”, PID2020-118658RB-I00, PDC2021–121572-100 cofunded by “European Union NextGeneration EU/PRTR”), Asociación Española Contra el Cáncer foundation (AECC; PROYE20089DELP); La Marató TV3 foundation (201936–30-31), Obra social La Caixa (AtheroConvergence, HR20–00075) and Comunidad Autónoma de Madrid/FEDER (Tec4Bio consortium, ref. S2018/NMT¬4443). MS-A is recipient of a Ramón y Cajal research contract from MCIN (RYC2020–029690-I) and research grant PID2021-128106NA-I00, both from Spanish MCIN. The CNIC is supported by the Instituto de Salud Carlos III (ISCIII), the Ministerio de Ciencia e Innovación (MCIN) and the Pro CNIC Foundation), and is a Severo Ochoa Center of Excellence (grant CEX2020–001041-S funded by MICIN/AEI/https://doi.org/10.13039/501100011033)., With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX2020–001041-S)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Detection of Carcinoma-Associated Fibroblasts Derived from Mesothelial Cells via Mesothelial-to-Mesenchymal Transition in Primary Ovarian Carcinomas

  • Tomero-Sanz, Henar
  • Jiménez-Heffernan, José Antonio
  • Fernández-Chacón, María Concepción
  • Cristóbal-García, Ignacio
  • Sainz de la Cuesta, Ricardo
  • González-Cortijo, Lucía
  • López-Cabrera, Manuel
  • Sandoval, Pilar
Carcinoma-associated fibroblasts (CAFs) are highly accumulated in the tumor-surrounding stroma of primary epithelial ovarian cancer (OC). CAFs exert important functions for the vascularization, growth, and progression of OC cells. However, the origin of CAFs in primary OC had not yet been studied, and they were assumed to arise from the activation of resident fibroblasts. Here, we compared CAFs in the ovary to CAFs found in peritoneal metastases from patients with advanced OC. Our findings show that CAFs from primary tumors and peritoneal metastases share the expression of mesothelial markers. Therefore, similar to peritoneal carcinomatosis, CAFs in primary ovarian carcinomas may originate from mesothelial cells via a mesothelial-to-mesenchymal transition. The detection of mesothelial-derived CAFs in tumors confined to the ovary and identification of biomarkers could be the key to the early detection of OC and peritoneal spread, This research was funded by the Spanish Ministry of Science and Innovation/Fondo Europeo de Desarrollo Regional (MICIN/FEDER), grant number PID2022-142796OB-I00/AEI/10.13039/501100011033 to MLC, Peer reviewed